GameDay Men's Health franchise: what the current FDD says
Independence note: this site is not affiliated with GameDay Men's Health. The name is used only to identify the company discussed (see the publisher disclosure in the footer). Figures below are dated; GameDay Men's Health’s current official documents control.
Franchise fee
~$49,500
All-in investment (Item 7)
~$224,000–$410,000
Ongoing take (Item 6)
6% royalty on gross + ~$2,000/mo local advertising
GameDay is the fastest-scaling franchise in the men's-health/metabolic lane: 257 franchised US locations across 37 states per the 2025 FDD, with the consumer site claiming "400+ clinics across the US & Canada." Franchise portals report over 1,000 licenses sold. That growth is genuine — and it is also where the sharpest diligence question lives (below).
The earnings picture — check the cohort dates
The headline performance figures widely quoted for this brand — roughly $1.89M average gross revenue and $627K average adjusted earnings — trace to an early cohort of units. Analyses of the more recent FDD data show materially lower figures for the broader system: on the order of $761K average gross and $114K–$152K owner earnings. Both sets of numbers can be simultaneously true; they describe different units in different years. Before relying on either, ask the franchisor which FDD year and which cohort each figure comes from, and what the median unit shows in the current Item 19.
Sold vs. open
Portals report 1,000+ licenses sold and 300+ locations awarded in a single year, against roughly 260 open units in the 2025 FDD. A gap between licenses sold and doors open is not unusual in fast-selling systems — but the size of the gap is a data point worth asking about directly: how many of the licenses sold in the last 24 months have opened?
The ongoing take
6% of gross plus a monthly local-advertising obligation, for the life of the agreement, on a brand the franchisee does not own. Run it at your own projected volume over ten years before comparing entry fees — the entry fee is the headline, the ongoing take is the business model.
Regulatory surface
This is a prescription-medicine model (testosterone replacement, GLP-1 weight loss), which means per-clinic medical oversight and prescribing compliance at every location. The company also currently faces a pending class action relating to website tracking pixels; as with any pending matter, no outcome should be assumed.
Take these questions to them
“Which FDD year and cohort do the headline earnings figures come from — and what is the current median unit?”
“How many of the licenses sold in the last 24 months have opened their doors?”
“What do 6% of gross plus advertising obligations total over ten years at my projected volume?”
“Who carries the medical and regulatory risk on TRT and GLP-1 prescribing at my location?”
Where we stand — disclosedThis site is published by Atlas Metabolic, which offers a 0%-royalty license model in this category (partner owns their own brand; final agreements control). We think the honest comparison — documents, fees, ownership at exit — favors that structure, and you should verify that skepticism-first: see how Atlas structures it, and hold us to the same diligence standard this site applies to everyone else. If you want to see ongoing-fee structures side by side at your own numbers, use the RoyaltyMath calculator.
Sources & dates (retrieved July 29, 2026 unless noted)
GameDay Men's Health 2025 FDD unit and fee data as digested by franchise-analytics services (sharpsheets.io; vettedbiz.com).